News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Steven Frank: Phase III Level I evidence for proton therapy in head and neck malignancies to be presented at ASCO
Photo from Steven Frank/X
May 29, 2024, 09:13

Steven Frank: Phase III Level I evidence for proton therapy in head and neck malignancies to be presented at ASCO

Steven Frank, Executive Director of Particle Therapy Institute at MD Anderson Cancer Center, shared on X:

“Congratulations to all participating institutions for driving Phase III Level I evidence for proton therapy in head and neck malignancies to be presented at ASCO on June 4th.”         .

View additional information.
Source: Steven Frank/X

ASCO24 cancer head and neck malignancies OncoDaily Oncology proton therapy Steven Frank The University of Texas MD Anderson Cancer Center
Special Coverage
Blog
Jan 23, 2025, 14:53
The PAINT Cancer Awareness and Hope event hosted by Cancer Fight Tanzania
Insight
Jan 23, 2025, 14:52
Debate Highlights Presented by Matti Aapro: Should All HR+/HER2- Metastatic Breast Cancer Patients Receive CDK4/6 Inhibitors in the First Line?
Insight
Jan 23, 2025, 14:43
Prof. Joseph Gligorov at BGICC 2025: Should All HR+/HER2- Metastatic Breast Cancer Patients Receive CDK4/6 Inhibitors in the First Line?
Blog
Jan 23, 2025, 14:43
AACR Forum on Exploring a New Generation of Patient-Centric Cancer Clinical Trials
Blog
Jan 23, 2025, 14:33
Elvina Almuradova: Improving Cancer Outcomes and Leadership Course
Science
Jan 23, 2025, 14:32
The EP3-ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
Insight
Jan 23, 2025, 14:32
Transition metal complexes as an approach for targeting emerging cancer hallmarks - The Babak Lab
Blog
Jan 23, 2025, 14:32
Amer Zeidan: Insights from the Most Important MDS Studies at ASH24
Blog
Jan 23, 2025, 14:32
Sharron Moffatt: It shouldn’t take bravery to tell your boss you have cancer
Blog
Jan 23, 2025, 14:32
Erika Hamilton: A true team at Sarah Cannon Research Institute
Blog
Jan 23, 2025, 14:32
Oscar Tahuahua: ctDNA could offer hope for NSCLC management
Blog
Jan 23, 2025, 14:32
Amol Akhade: Does CTRT improve outcomes in gall bladder cancer?